Canadian Surgery Forum 2014

Total Page:16

File Type:pdf, Size:1020Kb

Canadian Surgery Forum 2014 Vol. 57 (4 Suppl 1) August/août 2014 canjsurg.ca DOI: 10.1503/cjs.009414 Canadian Surgery Forum canadien de Forum chirurgie Abstracts of presentations to the Résumés des communications Annual Meetings of the présentées aux congrès annuels de Canadian Association l’Association canadienne of Bariatric Physicians des médecins et chirurgiens and Surgeons bariatriques Canadian Association Association canadienne of General Surgeons des chirurgiens généraux Canadian Association l’Association canadienne of Thoracic Surgeons des chirurgiens thoraciques Canadian Hepato-Pancreato- Canadian Hepato-Pancreato- Biliary Association Biliary Association Canadian Society of la Société canadienne Surgical Oncology d’oncologie chirurgicale Canadian Society la Société canadienne des of Colon and chirurgiens du côlon Rectal Surgeons et du rectum Vancouver, BC Vancouver (C-B) Sept. 17–21, 2013 du 17 au 21 sept., 2013 Abstracts • Résumés FORUM CANADIEN DE CHIRURGIE 2014 Canadian Association of Bariatric Physicians and Surgeons Association canadienne des médecins et chirurgiens bariatriques 1 This retrospective study evaluated the short-term outcomes of (CJS Editors' Choice Award) Weight loss and obesity- our first 162 laparoscopic sleeve gastrectomies. related outcomes of gastric bypass, sleeve gastrectomy Between August 2010 and February 2013, 212 patients under- and gastric banding in patients enrolled in a population- went LSG as a sole bariatric operation. A retrospective review of based bariatric program: prospective cohort study. a prospectively collected database was performed. Postoperative R.S. Gill, S. Apte, S. Majumdar, C. Agborsangaya, complications and weight loss at 12 months were examined. C. Rueda-Clausen, D. Birch, S. Karmali, S. Klarenbach, Quality of life (using IWQOL-lite and EQ-5D) and diabetes reso- A. Sharma, R.S. Padwal. From the University of Alberta, lution were also examined. Data were analyzed using a Student t Edmonton, Alta. test or χ2 test where appropriate. Thus far, data hava been collected on 162 patients with average Bariatric care is increasingly being delivered in Canada within follow-up of 138 days (SD 113). The mean age was 43.9 (SD 9.6) publicly funded regional programs. The optimal bariatric surgi- and there were 131 females. Mean initial body weight (kg) and cal procedure for severely obese individuals receiving bariatric BMI were 134.6 (SD 52.6) and 48.5 (SD 6.8). The majority of care is currently unknown. The objective of this population- these patients 106 (73.2%) had 4 or more comorbidities. based prospective cohort study was to compare the effectiveness Median length of hospital stay was 2 days. There were no con- of laparoscopic Roux-en-Y gastric bypass (LRYGB), laparo- versions to open surgery. scopic sleeve gastrectomy (LSG), and laparoscopic adjustable In terms of complications, there were 3 staple line leaks gastric banding (LAGB) in severely obese patients. (1.85%; 1 required early reoperation and the other 2 presented A total of 150 consecutive patients (51 LRYGB; 51 LSG; 10 days later with small intra-abdominal collections that resolved 48 LAGB) from the population-representative, publicly funded with conservative measures), 1 gastric volvulus that required early Weight Wise bariatric program were examined. The primary out- reoperation, and 2 patients experienced a pulmonary embolus come was weight change (kg). Between-group changes were analyzed (1.23%). One patient required a blood transfusion in the early using multivariable regression adjusted for age, sex, and baseline postoperative period. There were 2 superficial wound infections weight. Last-observation-carried-forward imputation was used for (1.23%). Two patients developed postoperative dysphagia missing data. (1.85%) requiring endoscopic dilation. At baseline, mean age was 43.5 ± 9.5 years, 87.3% were females and At 12 months, there were 67 patients with a mean body weight overall preoperative BMI was 46.2 ± 7.4 kg/m2. Absolute (kg) and relative (kg) BMI of 93.4 (SD 15.9; p < 0.0001) and 34.4 (SD 4.8; p < (% of baseline) mean weight losses were 36.6 ± 19.5 kg (26.1% ± 12.2%) 0.0001). Of the 56 patients with type 2 diabetes, 35 (62.5%) for LRYGB, 21.4 ± 16.0 kg (16.4% ± 11.6%) in for LSG, and 7.0 ± achieved remission within 12 months and this occurred most fre- 9.7 kg (5.8% ± 7.9%) for LAGB (p < 0.0001 for between-group compari- quently within 3 months 23 (41.1%). At 12-month follow-up, sons) at 2 years. Change in BMI was significantly greater in the LRYGB only 23.5% of this group was taking antidiabetic medication. All (–13.0 ± 6.6 kg/m2) group compared with both the LSG (–7.6 ± 5.7 34 pre-diabetics achieved remission within 6 months. In terms of kg/m2) and the LAGB (–2.6 ± 3.5 kg/m2) groups (p < 0.0001 for between- quality of life, the mean EQ-5D VAS score improved from 59.62 group comparisons). In addition, change in BMI was significantly greater to 82.92 (p < 0.05) and the mean IWQOL-lite score improved in the LSG group compared with the LAGB group (p < 0.05). Hyperten- from 44 to 86 (p < 0.05). sion, diabetes, and dyslipidemia prevalence’s decreased to a significantly Laparoscopic sleeve gastrectomy is a safe and effective bariatric greater degree with LRYGB compared with LAGB (p < 0.05). procedure. Resolution of comorbidity and improvement in qual- In a publicly funded bariatric surgery program providing ity of life in our small, rural program is comparable with that population-based bariatric care to severely obese individuals, reported in the literature. LRYGB and LSG demonstrated greater weight loss than LAGB. LRYGB was more effective than LAGB in improving obesity- 3 related comorbidities. Is early discharge of patients post-laparoscopic Roux-en-Y gastric bypass safe? A. Bazzarelli, R. Wu, 2 F. Haggar, A. Neville, J. Yelle, I. Raiche, J. Mamazza. From Early outcomes of a small, rural bariatric surgery the Ottawa Hospital, Ottawa, Ont. program. D. Pace, L. Twells, C. Smith, D. Boone, K. Manning, K. Lester, C. Dillon, W. Midozi, R. Murphy, Bariatric surgery cases have risen significantly in order to combat L. Bartlett, D. Gregory. From Memorial University, St. the obesity epidemic. The timing and related safety of early dis- John’s, Nlfd. charge after laparoscopic Roux-en-Y gastric bypass (LRYGB) is S86 J can chir, Vol. 57 (4 Suppl 1) août 2014 — Résumés © 2014 Association médicale canadienne CANADIAN SURGERY FORUM 2014 still debated, and the safety of early discharge (< 24 h) after sur- decreased by over 20 minutes as experience with LRYGB gery remains unclear. The objective of this study was to examine increased (153.9 v. 133.3 min; p < 0.001). Similarly, unexpected the impact of early discharge on surgery related readmission fol- return to the operating room decreased following the first 150 lowing LRYGB. cases (5.3% unexpected return v. 2.6%; p = 0.08). A retrospective review of patients undergoing LRYGB from Laparoscopic Roux-en-Y gastric bypass is a technically September 2009 to March 2011 at the Ottawa Hospital was per- demanding procedure with an appreciable learning curve. Results formed. Discharge readiness was determined by adequate PO anal- from this single-centre retrospective cohort study demonstrate gesia, tolerating fluids, voiding well, ambulating without assistance that as experience with this advanced laparoscopic procedure and absence of tachycardia. Fisher exact tests or χ2 tests were used increases, operative time among surgeons decreases. Unexpected for categorical variables and student t tests for continuous variables return to the operating room, on the other hand, does not appear to compare differences between patients discharged on postopera- to be affected by experience. Additional studies encompassing tive day (POD) 1 (< 24 h) and those discharged on POD 2 or 3. more specific short-term outcomes are required to fully elucidate A total of 638 patients were included. Thirty-four patients this learning curve. were discharged on POD 1 (early DC) and 604 patients were dis- charged on POD 2 or 3 (standard DC). The 30-day readmission 5 rates were not different between early DC and standard DC (p = Bariatric surgery in patients with renal disease: Is it safe 1.0). There were 2 readmissions in the early DC group (5.88%) and is there an optimal approach? F. Saleh. From the Uni- as compared with 47 readmissions in the standard DC group versity of Toronto, Toronto, Ont. (7.78%). The 2 groups (early DC v. standard DC) were compara- ble in terms of mean age (44.38 v. 45.72 yr, p = 0.49), sex (77% Obesity rates among patients with chronic kidney disease (CKD) female v. 82%, p = 0.36), mean BMI (48.21 v. 59.44, p = 0.28), and end-stage renal disease (ESRD) mirror that of the general perioperative risks as indicated by the American Society of Anes- population. With growing interest to offer bariatric surgery to thesiologists (ASA) score (71% v. 79% ASA 3, p = 0.05), and total these patients, concerns remain regarding safety. number of concurrent intraoperative procedures (11.8% v. The American College of Surgeons National Surgery Quality 10.6%, p = 0.83). Improvement Program was used to collect on selected laparo- Early discharge from hospital within 24 hours after LRYGB scopic bariatric procedures between 2005 and 2011. Estimated appears to be safe and does not adversely affect readmission. Fast glomerular filtration rate (GFR) was calculated for each patient tracking patients following surgery may result in significant hos- and grouped according to their respective stages of CKD. Uni- pital cost savings and a reduction waiting lists. variate and multivariate analyses were used to compare complica- tion rates across stages of GFR for the Roux-en-Y gastric bypass 4 (RYGB), laparoscopic adjustable gastric band (LAGB), and longi- Defining the learning curve: early experience of laparo- tudinal sleeve gastrectomy (LSG) separately.
Recommended publications
  • Unusual Case of Non-Resolving Necrotizing Pneumonia: a Last Resort Measure for Cure
    eCommons@AKU Department of Surgery Department of Surgery June 2016 Unusual case of non-resolving necrotizing pneumonia: a last resort measure for cure. Naseem Salahuddin Aga Khan University, [email protected] Naila Baig Ansari Aga Khan University Saulat H. Fatimi Aga Khan University, [email protected] Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_surg Part of the Surgery Commons Recommended Citation Salahuddin, N., Ansari, N., Fatimi, S. (2016). Unusual case of non-resolving necrotizing pneumonia: a last resort measure for cure.. JPMA: Journal of the Pakistan Medical Association, 66(6), 754-756. Available at: http://ecommons.aku.edu/pakistan_fhs_mc_surg_surg/566 754 CASE REPORT Unusual case of non-resolving necrotizing pneumonia: A last resort measure for cure Naseem Salahuddin, 1 Naila Baig-Ansari, 2 Saulat Hasnain Fatimi 3 Abstract pathogen of acute CAP, 2,3 and accounts for most cases of To our knowledge, this is an unusual case of a community- slowly resolving pneumonia.The majority of previously acquired pneumonia (CAP) with sepsis secondary to healthy hospitalized patients with severe CAP responded Streptococcus pneumoniae that required lung resection satisfactorily to prompt initiation of appropriate antibiotic for a non-resolving consolidation. A 74 year old previously therapy; however, it is estimated that 10% of hospitalized healthy woman, presented with acute fever, chills and CAP patients have slowly resolving or nonresolving pleuritic chest pain in Emergency Department (ED). A disease. 4 diagnosis of CAP was established with a Pneumonia Severity Index CURB-65 score of 5/5. In the ER, she was Case Report promptly and appropriately managed with antibiotics History: A 74 year old woman who was previously and aggressive supportive therapy.
    [Show full text]
  • Toman's Tuberculosis Case Detection, Treatment, and Monitoring
    TOMAN’S TUBERCULOSIS TOMAN’S TUBERCULOSIS CASE DETECTION, TREATMENT, AND MONITORING The second edition of this practical, authoritative reference book provides a rational basis for the diagnosis and management of tuberculosis. Written by a number of experts in the field, it remains faithful to Kurt Toman’s original question-and-answer format, with subject matter grouped under the three headings Case detection, Treatment, and Monitoring. It is a testament to the enduring nature of the first edition that so much CASE DETECTION, TREA material has been retained unchanged. At the same time, the new edition has had not only to address the huge resurgence of tuber- culosis, the emergence of multidrug-resistant bacilli, and the special needs of HIV-infected individuals with tuberculosis, but also to encompass significant scientific advances. These changes in the profile of the disease and in approaches to management have inevitably prompted many new questions and answers and given a different complexion to others. Toman’s Tuberculosis remains essential reading for all who need to AND MONITORING TMENT, QUESTIONS learn more about every aspect of tuberculosis – case-finding, manage- ment, and effective control strategies. It provides invaluable support AND to anyone in the front line of the battle against this disease, from ANSWERS programme managers to policy-makers and from medical personnel to volunteer health workers. SECOND EDITION ISBN 92 4 154603 4 WORLD HEALTH ORGANIZATION WHO GENEVA Toman’s Tuberculosis Case detection, treatment, and monitoring – questions and answers SECOND EDITION Edited by T. Frieden WORLD HEALTH ORGANIZATION GENEVA 2004 WHO Library Cataloguing-in-Publication Data Toman’s tuberculosis case detection, treatment, and monitoring : questions and answers / edited by T.
    [Show full text]
  • Translational Deep Phenotyping of Deaths Related to the COVID-19 Pandemic: Protocol for a Prospective Observational Autopsy Study
    Open access Protocol BMJ Open: first published as 10.1136/bmjopen-2021-049083 on 27 August 2021. Downloaded from Translational deep phenotyping of deaths related to the COVID-19 pandemic: protocol for a prospective observational autopsy study Mikkel Jon Henningsen ,1 Apameh Khatam- Lashgari,1 Kristine Boisen Olsen,1 Christina Jacobsen,1 Christian Beltoft Brøchner ,2 Jytte Banner1 To cite: Henningsen MJ, ABSTRACT Strengths and limitations of this study Khatam- Lashgari A, Olsen KB, Introduction The COVID-19 pandemic is an international et al. Translational deep emergency with an extreme socioeconomic impact and a ► A standardised, prospective autopsy study on COVID- phenotyping of deaths high mortality and disease burden. The COVID-19 outbreak related to the COVID-19 19- related deaths with systematic data collection. is neither fully understood nor fully pictured. Autopsy studies pandemic: protocol for a ► A multidisciplinary, translational approach elucidat- can help understand the pathogenesis of COVID-19 and has prospective observational ing changes from protein level to whole human. already resulted in better treatment of patients. Structured autopsy study. BMJ Open ► A comprehensive biobank and extensive registry and systematic autopsy of COVID-19- related deaths will 2021;11:e049083. doi:10.1136/ data as an umbrella for planned and future research. bmjopen-2021-049083 enhance the mapping of pathophysiological pathways, not ► The internal control group partly compensates for possible in the living. Furthermore, it provides an opportunity Prepublication history and the observational design. ► to envision factors translationally for the purpose of disease additional supplemental material ► Limited by a selected sample of COVID-19 diseased prevention in this and future pandemics.
    [Show full text]
  • Treatment and Outcomes of Community-Acquired Pneumonia at Canadian Hospitals Research Brian G
    Treatment and outcomes of community-acquired pneumonia at Canadian hospitals Research Brian G. Feagan,* Thomas J. Marrie,† Catherine Y. Lau,‡ Recherche Susan L. Wheeler,‡ Cindy J. Wong,* Margaret K. Vandervoort* From *the London Clinical Abstract Trials Research Group, London, Ont.; †the Background: Community-acquired pneumonia is a common disease with a large Department of Medicine, economic burden. We assessed clinical practices and outcomes among patients University of Alberta, with community-acquired pneumonia admitted to Canadian hospitals. Edmonton, Alta.; Methods: A total of 20 hospitals (11 teaching and 9 community) participated. Data and ‡Janssen–Ortho from the charts of adults admitted during November 1996, January 1997 and Incorporated, Toronto, Ont. March 1997 were reviewed to determine length of stay (LOS), admission to an intensive care unit and 30-day in-hospital mortality. Multivariate analyses exam- This article has been peer reviewed. ined sources of variability in LOS. The type and duration of antibiotic therapy and the proportion of patients who were treated according to clinical practice CMAJ 2000;162(10):1415-20 guidelines were determined. Results: A total of 858 eligible patients were identified; their mean age was 69.4 (standard deviation 17.7) years. The overall median LOS was 7.0 days (in- terquartile range [IQR] 4.0–11.0 days); the median LOS ranged from 5.0 to 9.0 days across hospitals (IQR 6.0–7.8 days). Only 22% of the variability in LOS could be explained by known factors (disease severity 12%; presence of chronic obstructive lung disease or bacterial cause for the pneumonia 2%; hospital site 7%).
    [Show full text]
  • Identification of Two Novel LAMP2 Gene Mutations in Danon Disease
    The Laryngoscope © 2016 the American Laryngological, Rhinological and Otological Society, Inc. Rotational Thyrotracheopexy After Cricoidectomy for Low-Grade Laryngeal Chrondrosarcoma László Rovó, MD, PhD; Ádám Bach, MD; Balázs Sztanó, MD, PhD; Vera Matievics, MD; Ilona Szegesdi, MD; Paul F. Castellanos, MD, FCCP Objectives:The complex laryngeal functions are fundamentally defined by the cricoid cartilage. Thus, lesions requiring subtotal or total resection of the cricoid cartilage commonly warrant total laryngectomy. However, from an oncological per­ spective, the resection of the cricoid cartilage would be an optimal solution in these cases. The poor functional results of the few reported cases of total and subtotal cricoidectomy with different reconstruction techniques confirm the need for new approaches to reconstruct the infrastructure of the larynx post cricoidectomy. Study Design:Retrospective case series review. Methods:Four consecutive patients with low-grade chondrosarcoma were treated by cricoidectomy with rotational thy­ rotracheopexy reconstruction to enable the functional creation of a complete cartilaginous ring that can substitute the func­ tions of the cricoid cartilage. The glottic structures were stabilized with endoscopic arytenoid abduction lateropexy. Patients were evaluated with objective and subjective function tests. Results: Tumor-free margins were proven; patients were successfully decannulated within 3 weeks. Voice outcomes were adequate for social conversation in all cases. Oral feeding was possible in three patients. Conclusion:Total and subtotal cricoidectomy can be a surgical option to avoid total laryngectomy in cases of large chondrosarcomas destroying the cricoid cartilage. The thyrotracheopexy rotational advancement technique enables the effec­ tive reconstruction of the structural deficit of the resected cricoid cartilage in cases of total and subtotal cricoidectomy.
    [Show full text]
  • Respiratory Tract Infections in the Tropics
    9.1 CHAPTER 9 Respiratory Tract Infections in the Tropics Tim J.J. Inglis 9.1 INTRODUCTION Acute respiratory infections are the single most common infective cause of death worldwide. This is also the case in the tropics, where they are a major cause of death in children under five. Bacterial pneumonia is particularly common in children in the tropics, and is more often lethal. Pulmonary tuberculosis is the single most common fatal infection and is more prevalent in many parts of the tropics due to a combination of endemic HIV infection and widespread poverty. A lack of diagnostic tests, limited access to effective treatment and some traditional healing practices exacerbate the impact of respiratory infection in tropical communities. The rapid urbanisation of populations in the tropics has increased the risk of transmitting respiratory pathogens. A combination of poverty and overcrowding in the peri- urban zones of rapidly expanding tropical cities promotes the epidemic spread of acute respiratory infection. PART A. INFECTIONS OF THE LOWER RESPIRATORY TRACT 9.2 PNEUMONIA 9.2.1 Frequency Over four million people die from acute respiratory infection per annum, mostly in developing countries. There is considerable overlap between these respiratory deaths and deaths due to tuberculosis, the single commonest fatal infection. The frequency of acute respiratory infection differs with location due to host, pathogen and environmental factors. Detailed figures are difficult to find and often need to be interpreted carefully, even for tuberculosis where data collection is more consistent. But in urban settings the enormity of respiratory infection is clearly evident. Up to half the patients attending hospital outpatient departments in developing countries have an acute respiratory infection.
    [Show full text]
  • Surgical Management of Laryngotracheal Stenosis in Adults
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Serveur académique lausannois Eur Arch Otorhinolaryngol (2005) 262: 609–615 DOI 10.1007/s00405-004-0887-9 LARYNGOLOGY Mercy George Æ Florian Lang Æ Philippe Pasche Philippe Monnier Surgical management of laryngotracheal stenosis in adults Received: 22 July 2004 / Accepted: 18 October 2004 / Published online: 25 January 2005 Ó Springer-Verlag 2005 Abstract The purpose was to evaluate the outcome fol- the efficacy and reliability of this approach towards the lowing the surgical management of a consecutive series management of laryngotracheal stenosis of varied eti- of 26 adult patients with laryngotracheal stenosis of ologies. Similar to data in the literature, post-intubation varied etiologies in a tertiary care center. Of the 83 pa- injury was the leading cause of stenosis in our series. A tients who underwent surgery for laryngotracheal ste- resection length of up to 6 cm with laryngeal release nosis in the Department of Otorhinolaryngology and procedures (when necessary) was found to be technically Head and Neck Surgery, University Hospital of Lau- feasible. sanne, Switzerland, between 1995 and 2003, 26 patients were adults (‡16 years) and formed the group that was Keywords Laryngotracheal stenosis Æ Laryngotracheal the focus of this study. The stenosis involved the trachea resection Æ Anastomosis (20), subglottis (1), subglottis and trachea (2), glottis and subglottis (1) and glottis, subglottis and trachea (2). The etiology of the stenosis was post-intubation injury (n =20), infiltration of the trachea by thyroid tumor (n Introduction =3), seeding from a laryngeal tumor at the site of the tracheostoma (n =1), idiopathic progressive subglottic In the majority of patients, acquired stenosis of the sub- stenosis (n =1) and external laryngeal trauma (n =1).
    [Show full text]
  • 2017 Pulmonary Coding and Payment Quick Reference
    2017 Coding & Payment Quick Reference Select Pulmonary Procedures Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding or site of service requirements. The coding options listed within this guide are commonly used codes and are not intended to be an all-inclusive list. We recommend consulting your relevant manuals for appropriate coding options. Medicare Physician, Hospital Outpatient, and ASC Payments The bronchoscopy procedures listed below (except CPT® Codes 31622, 31660, and 31661) all include a diagnostic bronchoscopy when performed by the same physician. 2017 Medicare National Average Payment RVUs Physician‡,2 Facility3 CPT® Total Total Hospital Code Description Work In-Office In-Facility ASC Code1 Office Facility Outpatient Biopsy 31625 Bronchoscopy, rigid or flexible, including fluoroscopic guidance, 3.11 9.43 4.53 $338 $163 $1,270† $569 when performed; with bronchial or endobronchial biopsy(s), single or multiple sites 31628 Bronchoscopy, rigid or flexible, including fluoroscopic guidance, 3.55 10.00 5.09 $359 $183 $2,431† $1,117 when performed; with transbronchial lung biopsy(s), single lobe 31632 Bronchoscopy, rigid or flexible, including fluoroscopic guidance, 1.03 1.84 1.42 $66 $51 $0 $0 when performed; with transbronchial lung biopsy(s), each additional lobe (List separately in addition to code for primary procedure)* Cytology and Brush 31622 Bronchoscopy, rigid or flexible, including fluoroscopic guidance, 2.53 6.86 3.81 $246 $137 $1,270† $569 when performed; diagnostic,
    [Show full text]
  • Community Acquired Pneumonia
    Community Acquired Pneumonia MELISSA PALMER AGACNP Objectives Know the target population for the 2019 American Thoracic Society and Infectious Diseases Society of America (ATS/IDSA) Community-acquired Pneumonia (CAP) guidelines 2019 Know when to perform testing for CAP: sputum cultures, blood cultures, Legionella and pneumococcal urinary antigen testing, influenza testing, and procalcitonin Be able to discuss the utilization of steroids in patients with CAP Know the selection of initial empiric antibiotic therapy for community-acquired pneumonia and duration of treatment for inpatients Criteria for hospitalization versus the need for ICU admission in adults diagnosed with CAP based on Pneumonia severity index (PSI) compared to CURB-65 Discuss the differences between the 2019 and 2007 ATS/IDSA Community-acquired Pneumonia Guidelines. COVID-19 Identify and Isolate. Pneumonia and CAP definition Pneumonia Infection of the alveoli, distal airways and the interstitium of the lung. Clinical: a new or changing radiographic density (infiltrate). Usually accompanied by constitutional symptoms of lung inflammation. Community Acquired Pneumonia acquired outside the hospital Signs and symptoms of pneumonia with radiographic confirmation *Patient must not have been hospitalized nor resided in a long-term-care facility for, at minimum, 14 days prior to the onset of symptoms Impact of Pneumonia leading infectious cause of hospitalization and death among U.S. adults more than 1.5 million adults hospitalized annually medical costs exceeding
    [Show full text]
  • ICD-9-CM Procedures (FY10)
    2 PREFACE This sixth edition of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) is being published by the United States Government in recognition of its responsibility to promulgate this classification throughout the United States for morbidity coding. The International Classification of Diseases, 9th Revision, published by the World Health Organization (WHO) is the foundation of the ICD-9-CM and continues to be the classification employed in cause-of-death coding in the United States. The ICD-9-CM is completely comparable with the ICD-9. The WHO Collaborating Center for Classification of Diseases in North America serves as liaison between the international obligations for comparable classifications and the national health data needs of the United States. The ICD-9-CM is recommended for use in all clinical settings but is required for reporting diagnoses and diseases to all U.S. Public Health Service and the Centers for Medicare & Medicaid Services (formerly the Health Care Financing Administration) programs. Guidance in the use of this classification can be found in the section "Guidance in the Use of ICD-9-CM." ICD-9-CM extensions, interpretations, modifications, addenda, or errata other than those approved by the U.S. Public Health Service and the Centers for Medicare & Medicaid Services are not to be considered official and should not be utilized. Continuous maintenance of the ICD-9- CM is the responsibility of the Federal Government. However, because the ICD-9-CM represents the best in contemporary thinking of clinicians, nosologists, epidemiologists, and statisticians from both public and private sectors, no future modifications will be considered without extensive advice from the appropriate representatives of all major users.
    [Show full text]
  • IDSA/ATS Consensus Guidelines on The
    SUPPLEMENT ARTICLE Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults Lionel A. Mandell,1,a Richard G. Wunderink,2,a Antonio Anzueto,3,4 John G. Bartlett,7 G. Douglas Campbell,8 Nathan C. Dean,9,10 Scott F. Dowell,11 Thomas M. File, Jr.12,13 Daniel M. Musher,5,6 Michael S. Niederman,14,15 Antonio Torres,16 and Cynthia G. Whitney11 1McMaster University Medical School, Hamilton, Ontario, Canada; 2Northwestern University Feinberg School of Medicine, Chicago, Illinois; 3University of Texas Health Science Center and 4South Texas Veterans Health Care System, San Antonio, and 5Michael E. DeBakey Veterans Affairs Medical Center and 6Baylor College of Medicine, Houston, Texas; 7Johns Hopkins University School of Medicine, Baltimore, Maryland; 8Division of Pulmonary, Critical Care, and Sleep Medicine, University of Mississippi School of Medicine, Jackson; 9Division of Pulmonary and Critical Care Medicine, LDS Hospital, and 10University of Utah, Salt Lake City, Utah; 11Centers for Disease Control and Prevention, Atlanta, Georgia; 12Northeastern Ohio Universities College of Medicine, Rootstown, and 13Summa Health System, Akron, Ohio; 14State University of New York at Stony Brook, Stony Brook, and 15Department of Medicine, Winthrop University Hospital, Mineola, New York; and 16Cap de Servei de Pneumologia i Alle`rgia Respirato`ria, Institut Clı´nic del To`rax, Hospital Clı´nic de Barcelona, Facultat de Medicina, Universitat de Barcelona, Institut d’Investigacions Biome`diques August Pi i Sunyer, CIBER CB06/06/0028, Barcelona, Spain. EXECUTIVE SUMMARY priate starting point for consultation by specialists. Substantial overlap exists among the patients whom Improving the care of adult patients with community- these guidelines address and those discussed in the re- acquired pneumonia (CAP) has been the focus of many cently published guidelines for health care–associated different organizations, and several have developed pneumonia (HCAP).
    [Show full text]
  • Medical and Surgical Management of Empyema
    361 Medical and Surgical Management of Empyema Mark S. Godfrey, MD1 Kyle T. Bramley, MD1 Frank Detterbeck, MD2 1 Pulmonary, Critical Care and Sleep Medicine, Yale New Haven Address for correspondence Frank Detterbeck, MD, 330 Cedar Street, Hospital, New Haven, Connecticut P.O. Box 208062, New Haven, CT 06520 2 Section of Thoracic Surgery, Yale University School of Medicine, (e-mail: [email protected]). New Haven, Connecticut Semin Respir Crit Care Med 2019;40:361–374. Abstract Infection of the pleural space is an ancient and common clinical problem, the incidence which is on the rise. Advances in therapy now present clinicians of varying disciplines with an array of therapeutic options ranging from thoracentesis and chest tube drainage (with or without intrapleural fibrinolytic therapies) to video-assisted thoracic surgery (VATS) or thoracotomy. A framework is provided to guide decision making, which involves weighing multiple factors (clinical history and presentation, imaging characteristics, comorbidities); Keywords multidisciplinary collaboration and active management are needed as the clinical course ► empyema over a few days determines subsequent refinement. The initial choice of antibiotics depends ► pleural infection on whether the empyema is community-acquired or nosocomial, and clinicians must ► tissue plasminogen recognize that culture results often do not reflect the full disease process. Antibiotics alone activator are rarely successful and can be justified only in specific circumstances. Early drainage with ► deoxyribonuclease or without intrapleural fibrinolytics is usually required. This is successful in most patients; ► thoracoscopy however, when surgical decortication is needed, clear benefit and low physiologic impact ► video-assisted are more likely with early intervention, expeditious escalation of interventions, and care at a thoracic surgery center experienced with VATS.
    [Show full text]